88 related articles for article (PubMed ID: 2876756)
1. Perinatal dietary supplementation with a soy lecithin preparation: effects on development of central catecholaminergic neurotransmitter systems.
Bell JM; Whitmore WL; Cowdery T; Slotkin TA
Brain Res Bull; 1986 Aug; 17(2):189-95. PubMed ID: 2876756
[TBL] [Abstract][Full Text] [Related]
2. Perinatal dietary supplementation with a commercial soy lecithin preparation: effects on behavior and brain biochemistry in the developing rat.
Bell JM; Slotkin TA
Dev Psychobiol; 1985 Sep; 18(5):383-94. PubMed ID: 2415412
[TBL] [Abstract][Full Text] [Related]
3. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain.
Rastogi RB; Singhal RL
J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462
[TBL] [Abstract][Full Text] [Related]
4. Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems.
Bartolome J; Whitmore WL; Seidler FJ; Slotkin TA
Life Sci; 1984 Aug; 35(6):657-70. PubMed ID: 6146912
[TBL] [Abstract][Full Text] [Related]
5. Undernutrition and overnutrition in the neonatal rat: long-term effects on noradrenergic pathways in brain regions.
Seidler FJ; Bell JM; Slotkin TA
Pediatr Res; 1990 Feb; 27(2):191-7. PubMed ID: 2156213
[TBL] [Abstract][Full Text] [Related]
6. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways.
Slotkin TA; Cho H; Whitmore WL
Brain Res Bull; 1987 May; 18(5):601-11. PubMed ID: 3607529
[TBL] [Abstract][Full Text] [Related]
7. Perinatal dietary exposure to soy lecithin: altered sensitivity to central cholinergic stimulation.
Bell JM; Whitmore WL; Barnes G; Seidler FJ; Slotkin TA
Int J Dev Neurosci; 1986; 4(6):497-501. PubMed ID: 3455608
[TBL] [Abstract][Full Text] [Related]
8. Persisting effects on adult brain monoamines of neonatal distress and carbon monoxide exposure.
Shellenberger MK
Neuroscience; 1982 Mar; 7(3):667-71. PubMed ID: 6122189
[TBL] [Abstract][Full Text] [Related]
9. Impaired development of central and peripheral catecholamine neurotransmitter systems in preweanling rats treated with alpha-difluoromethylornithine, a specific irreversible inhibitor of ornithine decarboxylase.
Slotkin TA; Grignolo A; Whitmore WL; Lerea L; Trepanier PA; Barnes GA; Weigel SJ; Seidler FJ; Bartolome J
J Pharmacol Exp Ther; 1982 Sep; 222(3):746-51. PubMed ID: 6125588
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical characteristics of cerebral catecholamine neurons during the postnatal development in the rat.
Hedner T; Lundborg P
Med Biol; 1981 Aug; 59(4):212-23. PubMed ID: 6803074
[TBL] [Abstract][Full Text] [Related]
11. Neonatal methylmercury poisoning in the rat: effects on development of central catecholamine neurotransmitter systems.
Bartolome J; Trepanier P; Chait EA; Seidler FJ; Deskin R; Slotkin TA
Toxicol Appl Pharmacol; 1982 Aug; 65(1):92-9. PubMed ID: 6128806
[No Abstract] [Full Text] [Related]
12. Distinct, developmentally regulated brain mRNAs direct the synthesis of neurotransmitter transporters.
Blakely RD; Clark JA; Pacholczyk T; Amara SG
J Neurochem; 1991 Mar; 56(3):860-71. PubMed ID: 1671586
[TBL] [Abstract][Full Text] [Related]
13. Effects of a commercial soy lecithin preparation on development of sensorimotor behavior and brain biochemistry in the rat.
Bell JM; Lundberg PK
Dev Psychobiol; 1985 Jan; 18(1):59-66. PubMed ID: 4038491
[TBL] [Abstract][Full Text] [Related]
14. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems.
Navarro HA; Seidler FJ; Whitmore WL; Slotkin TA
J Pharmacol Exp Ther; 1988 Mar; 244(3):940-4. PubMed ID: 3252040
[TBL] [Abstract][Full Text] [Related]
15. Obligatory role of thyroid hormones in development of peripheral sympathetic and central nervous system catecholaminergic neurons: effects of propylthiouracil-induced hypothyroidism on transmitter levels, turnover and release.
Slotkin TA; Slepetis RJ
J Pharmacol Exp Ther; 1984 Jul; 230(1):53-61. PubMed ID: 6747831
[TBL] [Abstract][Full Text] [Related]
16. Changes in catecholamine neuronal uptake and receptor binding in the brains of spontaneously hypertensive rats (SHR).
Myers MM; Whittemore SR; Hendley ED
Brain Res; 1981 Sep; 220(2):325-38. PubMed ID: 7284759
[TBL] [Abstract][Full Text] [Related]
17. Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catecholamines influence cell development.
Seidler FJ; Temple SW; McCook EC; Slotkin TA
Brain Res Dev Brain Res; 1995 Mar; 85(1):48-53. PubMed ID: 7781166
[TBL] [Abstract][Full Text] [Related]
18. Heroin neuroteratogenicity: delayed-onset deficits in catecholaminergic synaptic activity.
Slotkin TA; Seidler FJ; Yanai J
Brain Res; 2003 Sep; 984(1-2):189-97. PubMed ID: 12932853
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids and the development of neuronal function: effects of prenatal dexamethasone exposure on central noradrenergic activity.
Slotkin TA; Lappi SE; McCook EC; Tayyeb MI; Eylers JP; Seidler FJ
Biol Neonate; 1992; 61(5):326-36. PubMed ID: 1391259
[TBL] [Abstract][Full Text] [Related]
20. Action of lead on neurotransmission in rats.
McIntosh MJ; Meredith PA; Moore MR; Goldberg A
Xenobiotica; 1989 Jan; 19(1):101-13. PubMed ID: 2569255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
